What Are the Clinical Implications of Studying Low-Abundance Molecules?
Understanding and detecting low-abundance molecules can significantly impact clinical practice. For example, the detection of ctDNA can be used for liquid biopsy, a minimally invasive method for diagnosing and monitoring cancer. Additionally, identifying low-abundance mutations can help in the development of targeted therapies and personalized medicine approaches, improving treatment efficacy and patient outcomes.
